{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T11:04:54Z","timestamp":1780398294261,"version":"3.54.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T00:00:00Z","timestamp":1767139200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"vor","delay-in-days":26,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Natural Science Foundation of Xiamen","award":["3502Z202373140"],"award-info":[{"award-number":["3502Z202373140"]}]},{"name":"Natural Science Foundation of Xiamen","award":["3502Z202373100"],"award-info":[{"award-number":["3502Z202373100"]}]},{"name":"Key Project of Natural Science Foundation of Fujian Province","award":["2022J02056"],"award-info":[{"award-number":["2022J02056"]}]},{"name":"Key Project of Natural Science Foundation of Fujian Province","award":["2023D001"],"award-info":[{"award-number":["2023D001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-33330-x","type":"journal-article","created":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T07:14:00Z","timestamp":1767165240000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Sophoricoside from sophora japonica L. is efficacious as monotherapy or in combination with lenvatinib in hepatocellular carcinoma via targeting EGFR"],"prefix":"10.1038","volume":"16","author":[{"given":"Wenqing","family":"Xi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinzhu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changhong","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinliang","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuqiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengrong","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyu","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,31]]},"reference":[{"key":"33330_CR1","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1159\/000534513","volume":"13","author":"YK Sim","year":"2024","unstructured":"Sim, Y. K. et al. Real-World data on the Diagnosis, Treatment, and management of hepatocellular carcinoma in the Asia-Pacific: the INSIGHT study. Liver Cancer. 13, 298\u2013313. https:\/\/doi.org\/10.1159\/000534513 (2024).","journal-title":"Liver Cancer"},{"key":"33330_CR2","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1159\/000496439","volume":"8","author":"M Bouattour","year":"2019","unstructured":"Bouattour, M., Mehta, N., He, A. R., Cohen, E. I. & Nault, J. C. Systemic treatment for advanced hepatocellular carcinoma. Liver Cancer. 8, 341\u2013358. https:\/\/doi.org\/10.1159\/000496439 (2019).","journal-title":"Liver Cancer"},{"key":"33330_CR3","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","volume":"7","author":"JM Llovet","year":"2021","unstructured":"Llovet, J. M. et al. Hepatocellular carcinoma. Nat. Rev. Dis. Primers. 7, 6. https:\/\/doi.org\/10.1038\/s41572-020-00240-3 (2021).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"33330_CR4","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s40265-019-01116-x","volume":"79","author":"ZT Al-Salama","year":"2019","unstructured":"Al-Salama, Z. T., Syed, Y. Y., Scott, L. J. & Lenvatinib A review in hepatocellular carcinoma. Drugs 79, 665\u2013674. https:\/\/doi.org\/10.1007\/s40265-019-01116-x (2019).","journal-title":"Drugs"},{"key":"33330_CR5","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/s41586-021-03741-7","volume":"595","author":"H Jin","year":"2021","unstructured":"Jin, H. et al. EGFR activation limits the response of liver cancer to lenvatinib. Nature 595, 730\u2013734. https:\/\/doi.org\/10.1038\/s41586-021-03741-7 (2021).","journal-title":"Nature"},{"key":"33330_CR6","doi-asserted-by":"publisher","first-page":"155317","DOI":"10.1016\/j.phymed.2023.155317","volume":"128","author":"X Chen","year":"2024","unstructured":"Chen, X. et al. Withaferin A, a natural thioredoxin reductase 1 (TrxR1) inhibitor, synergistically enhances the antitumor efficacy of Sorafenib through ROS-mediated ER stress and DNA damage in hepatocellular carcinoma cells. Phytomedicine 128, 155317. https:\/\/doi.org\/10.1016\/j.phymed.2023.155317 (2024).","journal-title":"Phytomedicine"},{"key":"33330_CR7","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1002\/ptr.7637","volume":"37","author":"XF Zhu","year":"2023","unstructured":"Zhu, X. F. et al. Synergistic anticancer effect of flavonoids from sophora alopecuroides with Sorafenib against hepatocellular carcinoma. Phytother Res. 37, 592\u2013610. https:\/\/doi.org\/10.1002\/ptr.7637 (2023).","journal-title":"Phytother Res."},{"key":"33330_CR8","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.jep.2016.04.014","volume":"187","author":"X He","year":"2016","unstructured":"He, X. et al. Local and traditional uses, phytochemistry, and Pharmacology of sophora Japonica L.: A review. J. Ethnopharmacol. 187, 160\u2013182. https:\/\/doi.org\/10.1016\/j.jep.2016.04.014 (2016).","journal-title":"J. Ethnopharmacol."},{"key":"33330_CR9","doi-asserted-by":"publisher","first-page":"155846","DOI":"10.1016\/j.phymed.2024.155846","volume":"132","author":"Y Wu","year":"2024","unstructured":"Wu, Y. et al. Sophoricoside ameliorates methicillin-resistant Staphylococcus aureus-induced acute lung injury by inhibiting Bach1\/Akt pathway. Phytomedicine 132, 155846. https:\/\/doi.org\/10.1016\/j.phymed.2024.155846 (2024).","journal-title":"Phytomedicine"},{"key":"33330_CR10","doi-asserted-by":"publisher","first-page":"111886","DOI":"10.1016\/j.intimp.2024.111886","volume":"131","author":"Q Li","year":"2024","unstructured":"Li, Q. et al. Sophoricoside improved crohn\u2019s disease-like colitis by inhibiting intestinal epithelial cell apoptosis through PI3K\/AKT signaling. Int. Immunopharmacol. 131, 111886. https:\/\/doi.org\/10.1016\/j.intimp.2024.111886 (2024).","journal-title":"Int. Immunopharmacol."},{"key":"33330_CR11","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.biortech.2012.02.038","volume":"111","author":"J Wu","year":"2012","unstructured":"Wu, J. et al. Biotransformation of sophoricoside in fructus sophorae by the fungus schizophyllum commune. Bioresour Technol. 111, 496\u2013499. https:\/\/doi.org\/10.1016\/j.biortech.2012.02.038 (2012).","journal-title":"Bioresour Technol."},{"key":"33330_CR12","doi-asserted-by":"publisher","unstructured":"Chen, Y. et al. Sophoricoside attenuates autoimmune\u2013mediated liver injury through the regulation of oxidative stress and the NF\u2013\u03baB signaling pathway. Int. J. Mol. Med. 52 https:\/\/doi.org\/10.3892\/ijmm.2023.5281 (2023).","DOI":"10.3892\/ijmm.2023.5281"},{"key":"33330_CR13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/1878-0261.12155","volume":"12","author":"S Sigismund","year":"2018","unstructured":"Sigismund, S., Avanzato, D. & Lanzetti, L. Emerging functions of the EGFR in cancer. Mol. Oncol. 12, 3\u201320. https:\/\/doi.org\/10.1002\/1878-0261.12155 (2018).","journal-title":"Mol. Oncol."},{"key":"33330_CR14","doi-asserted-by":"publisher","unstructured":"Bang, J., Jun, M., Lee, S., Moon, H. & Ro, S. W. Targeting EGFR\/PI3K\/AKT\/mTOR signaling in hepatocellular carcinoma. Pharmaceutics 15 https:\/\/doi.org\/10.3390\/pharmaceutics15082130 (2023).","DOI":"10.3390\/pharmaceutics15082130"},{"key":"33330_CR15","doi-asserted-by":"publisher","first-page":"3845","DOI":"10.1158\/0008-5472.Can-21-4140","volume":"82","author":"B Hu","year":"2022","unstructured":"Hu, B. et al. Inhibition of EGFR overcomes acquired lenvatinib resistance driven by STAT3-ABCB1 signaling in hepatocellular carcinoma. Cancer Res. 82, 3845\u20133857. https:\/\/doi.org\/10.1158\/0008-5472.Can-21-4140 (2022).","journal-title":"Cancer Res."},{"key":"33330_CR16","doi-asserted-by":"publisher","unstructured":"Yuan, S. et al. Anticancer fungal natural products: mechanisms of action and biosynthesis. Eur. J. Med. Chem. 202 https:\/\/doi.org\/10.1016\/j.ejmech.2020.112502 (2020).","DOI":"10.1016\/j.ejmech.2020.112502"},{"key":"33330_CR17","doi-asserted-by":"publisher","unstructured":"Naeem, A. et al. Natural products as anticancer agents: current status and future perspectives. Molecules 27 https:\/\/doi.org\/10.3390\/molecules27238367 (2022).","DOI":"10.3390\/molecules27238367"},{"key":"33330_CR18","doi-asserted-by":"publisher","unstructured":"De Filippis, B., Fantacuzzi, M. & Ammazzalorso, A. Anticancer activity of natural products and related compounds. Int. J. Mol. Sci. 24 https:\/\/doi.org\/10.3390\/ijms242216507 (2023).","DOI":"10.3390\/ijms242216507"},{"key":"33330_CR19","doi-asserted-by":"publisher","unstructured":"Chen, Y. et al. Sophoricoside attenuates autoimmune\u2013mediated liver injury through the regulation of oxidative stress and the NF\u2013kappaB signaling pathway. Int. J. Mol. Med. 52 https:\/\/doi.org\/10.3892\/ijmm.2023.5281 (2023).","DOI":"10.3892\/ijmm.2023.5281"},{"key":"33330_CR20","doi-asserted-by":"publisher","first-page":"117105","DOI":"10.1016\/j.jep.2023.117105","volume":"319","author":"SH Han","year":"2024","unstructured":"Han, S. H., Lee, H. D., Lee, S. & Lee, A. Y. Taraxacum Coreanum Nakai extract attenuates lipopolysaccharide-induced inflammatory responses and intestinal barrier dysfunction in Caco-2 cells. J. Ethnopharmacol. 319, 117105. https:\/\/doi.org\/10.1016\/j.jep.2023.117105 (2024).","journal-title":"J. Ethnopharmacol."},{"key":"33330_CR21","doi-asserted-by":"publisher","first-page":"104069","DOI":"10.1016\/j.drudis.2024.104069","volume":"29","author":"FM Fan","year":"2024","unstructured":"Fan, F. M., Fleishman, J. S., Chen, J., Chen, Z. S. & Dong, H. H. New insights into the mechanism of resistance to lenvatinib and strategies for lenvatinib sensitization in hepatocellular carcinoma. Drug Discov Today. 29, 104069. https:\/\/doi.org\/10.1016\/j.drudis.2024.104069 (2024).","journal-title":"Drug Discov Today"},{"key":"33330_CR22","doi-asserted-by":"publisher","first-page":"118642","DOI":"10.1016\/j.lfs.2020.118642","volume":"264","author":"Z Zhao","year":"2021","unstructured":"Zhao, Z. et al. Oxysophocarpine suppresses FGFR1-overexpressed hepatocellular carcinoma growth and sensitizes the therapeutic effect of lenvatinib. Life Sci. 264, 118642. https:\/\/doi.org\/10.1016\/j.lfs.2020.118642 (2021).","journal-title":"Life Sci."},{"key":"33330_CR23","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.semcancer.2019.06.002","volume":"59","author":"S Revathidevi","year":"2019","unstructured":"Revathidevi, S. & Munirajan, A. K. Akt in cancer: mediator and more. Semin Cancer Biol. 59, 80\u201391. https:\/\/doi.org\/10.1016\/j.semcancer.2019.06.002 (2019).","journal-title":"Semin Cancer Biol."},{"key":"33330_CR24","doi-asserted-by":"publisher","first-page":"106553","DOI":"10.1016\/j.phrs.2022.106553","volume":"187","author":"MDA Paskeh","year":"2023","unstructured":"Paskeh, M. D. A. et al. Biological impact and therapeutic perspective of targeting PI3K\/Akt signaling in hepatocellular carcinoma: promises and challenges. Pharmacol. Res. 187, 106553. https:\/\/doi.org\/10.1016\/j.phrs.2022.106553 (2023).","journal-title":"Pharmacol. Res."},{"key":"33330_CR25","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s12672-024-00947-9","volume":"15","author":"Y Zong","year":"2024","unstructured":"Zong, Y., Tao, Z., Jiang, S., Wang, M. & Yu, W. Repression of LSD1\/KDM1A activity improves the response of liver cancer cells to the lenvatinib. Discover Oncol. 15, 89. https:\/\/doi.org\/10.1007\/s12672-024-00947-9 (2024).","journal-title":"Discover Oncol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-33330-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-33330-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-33330-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T01:04:18Z","timestamp":1769475858000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-33330-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,31]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["33330"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-33330-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,31]]},"assertion":[{"value":"18 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Approval for the experimental protocols was granted by the Ethics Committee of Zhongshan Hospital of Xiamen University. All experiments were performed in accordance with relevant guidelines and regulations. The Animal Care and Use Committee of Xiamen University granted approval for the animal study. All animal experiments complied with the ARRIVE guidelines and performed in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"3306"}}